Company Overview

Prolife Industries Limited was incorporated at Ankleshwar as "Mamta Dyes and Intermediates Private Limited" on July 27, 1994, with the Registrar of Companies at Gujarat, Dadra & Nagar Haveli. The company's name was changed from Mamta Dyes and Intermediates Limited to "R.R.J. Dyes and Intermediates Limited" on February 20, 1997, and later to "Prolife Industries Limited" vide a fresh Certificate of Incorporation dated March 7, 2013. The company made its public debut with an issue of 11,10,000 Equity Shares, raising capital aggregating to Rs. 4.2 Crore in December 2016.

Prolife Industries Limited is headquartered at 213, G.I.D.C. Panoli, Ankleshwar, Gujarat, 394116. The company operates under the CIN number L24231GJ1994PLC022613 and is listed on both NSE and BSE with the symbol PROLIFE. It has an authorized capital of ₹4.50 Cr and a paid-up capital of ₹4.09 Cr.

Business Operations and Products

The Company is engaged in the manufacturing of a special and exclusive range of intermediates for dyes, pigments, agrochemicals, pharmaceuticals, and others. Its product portfolio includes Dihydro Thio Para Toluidine Sulfonic Acid, Amino Methyl Phenoxy Sulfonic Acid, and other specialized intermediates.

Prolife Industries has established a strong global presence, with its main end product being Naphthalene-based Dyes & Intermediates. These are sold to well-known multinational trading houses in various countries, including the U.S.A., Spain, Switzerland, Germany, and France, as well as directly to customers in Taiwan, Japan, Italy, and Brazil. The company derives revenue from both domestic and overseas markets, which are considered as distinct geographical segments.

Market Position and Stock Performance

Prolife Industries Ltd (PROLIFE) belongs to the Materials sector, specifically the Commodity Chemicals sub-sector. As of the latest available data (04-Apr-2025), the company has a market capitalization of ₹92 Cr. Classified as a Small Cap company by Value Research, Prolife Industries Ltd has shown mixed stock performance recently. Over the past 6 months, its share price has increased by 0.07%, and by 0.2% in the last year. However, Prolife Industries Ltd has delivered a return of 7.15% over the last 3 years. The 52-week high for PROLIFE is ₹361, and the 52-week low is ₹187.

Financial Performance and Key Metrics

The company's financial metrics present a mixed picture, indicating potential challenges in its growth trajectory. Key financial indicators as of recent data include:

- P/E Ratio: 10.49 times (as on 04-Apr-2025), representing a 71% discount to its peers' median range of 36.32 times.

- P/B Ratio: 2.24 times (as on 04-Apr-2025), representing a 25% discount to its peers' median range of 2.97 times.

- Dividend Yield: 0.23% (current).

- Sales Growth: The company has delivered a poor sales growth of 1.94% over the past five years.

- FY2023 Performance: Reported revenue of ₹80.50 Cr and a net worth of ₹32.36 Cr.

- TTM Profit After Tax: ₹9 Cr (indicates recent profitability).

Workforce and Operations

Prolife Industries has a workforce of 59 employees as of April 1, 2024. The company maintains compliance with regulatory requirements, with its latest Annual General Meeting (AGM) held on September 23, 2024, and its balance sheet filed on March 31, 2024.

Management and Governance

The Managing Director of Prolife Industries is Karan Manindersingh Jolly. The company's leadership structure includes directors such as Keshavkumar Bipinkumar Singh, Veljibhai Kanjibhai Patel, and Dharmendra Mahendra Pushkarna. From a shareholding perspective, Promoter Holding stands at 73.7%, indicating strong promoter confidence in the business.

The company has maintained a clean financial structure with no open charges and ₹18.75 Cr in settled loans. Additionally, there is no promoter pledging reported for Prolife Industries Ltd.